Effect of alpha tocopherol acetate in Walker 256/B cells-induced oxidative damage in a rat model of breast cancer skeletal metastases

Chemico-Biological Interactions

Volumn 182, Issue 2-3, 2009, Pages 98-105

  Badraoui, Riadh ^a,b   Blouin, Stéphane ^a   Moreau, Marie Françoise ^a   Gallois, Yves ^a   Rebai, Tarek ^b   Sahnoun, Zouhaier ^b   Baslé, Michel ^a   Chappard, Daniel ^a  

^a Universite d'Angers   (France)

^b UNIVERSITY OF SFAX   (Tunisia)

Author keywords

Tocopherol acetate; Bone metastasis; Metaplasia; Osteolysis; Osteosclerosis; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BONE METASTASIS; BREAST CANCER; CELL CULTURE; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFICACY; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OXIDATIVE STRESS; TRABECULAR BONE;

ALPHA-TOCOPHEROL; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; BONE AND BONES; BONE NEOPLASMS; BREAST NEOPLASMS; CARCINOMA 256, WALKER; CELL LINE, TUMOR; FEMALE; LIPID PEROXIDATION; MALE; NEOPLASM TRANSPLANTATION; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

ANIMALIA; RATTUS;

EID: 70350130529     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2009.09.010     Document Type: Article

References (62)

1. Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2 8 (2002) 584-593
2. Coleman R.E. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat. Rev. 27 3 (2001) 165-176
3. Blouin S., Baslé M.F., and Chappard D. Rat models of bone metastases. Clin. Exp. Metastasis 22 8 (2005) 605-614
4. Blouin S., Moreau M.F., Baslé M.F., and Chappard D. Relations between radiograph texture analysis and microcomputed tomography in two rat models of bone metastases. Cells Tissues Organs 182 3-4 (2006) 182-192
5. Mao-Ying Q.L., Zhao J., Dong Z.Q., Wang J., Yu J., Yan M.F., Zhang Y.Q., Wu G.C., and Wang Y.Q. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochem. Biophys. Res. Commun. 345 4 (2006) 1292-1298
6. Hahn T., Szabo L., Gold M., Ramanathapuram L., Hurley L.H., and Akporiaye E.T. Dietary administration of the proapoptotic vitamin E analogue {alpha}-tocopheryloxyacetic acid inhibits metastatic murine breast cancer. Cancer Res. 66 19 (2006) 9374-9378
7. Abuja P.M., and Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin. Chim. Acta 306 1-2 (2001) 1-17
8. Niki E., Yoshida Y., Saito Y., and Noguchi N. Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem. Biophys. Res. Commun. 338 1 (2005) 668-676
9. Cerutti P.A., and Trump B.F. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 3 1 (1991) 1-7
10. Badraoui R., Sahnoun Z., Bouayed N.B., Hakim A., and Rebai T. May antioxidant status depletion by tetradifon induce secondary genotoxicity in female wistar rat via oxidative stress?. Pesticide Biochem. Physiol. 88 (2007) 149-155
11. Khanzode S.S., Muddeshwar M.G., Khanzode S.D., and Dakhale G.N. Antioxidant enzymes and lipid peroxidation in different stages of breast cancer. Free Radic. Res. 38 1 (2004) 81-85
12. Gonenc A., Erten D., Aslan S., Akinci M., Simsek B., and Torun M. Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol. Int. 30 4 (2006) 376-380
13. Henrotin Y., and Kurz B. Antioxidant to treat osteoarthritis: dream or reality?. Curr. Drug Targets 8 2 (2007) 347-357
14. Tain Y.L., Freshour G., Dikalova A., Griendling K.K., Baylis C., and Vitamin. E reduces glomerulosclerosis, restores renal neuronal NOS, and suppresses oxidative stress in the 5/6 nephrectomized rat. Am. J. Physiol. Renal Physiol. 292 (2007) 1404-1410
15. Yun J.S., Na H.K., Park K.S., Lee Y.H., Kim E.Y., Lee S.Y., Kim J.I., Kang J.H., Kim D.S., and Choi K.H. Protective effects of vitamin E on endocrine disruptors, PCB-induced dopaminergic neurotoxicity. Toxicology 216 2-3 (2005) 140-146
16. Kim H.J., Chang E.J., Kim H.M., Lee S.B., Kim H.D., Su Kim G., and Kim H.H. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic. Biol. Med. 40 9 (2006) 1483-1493
17. Drisko J.A., Chapman J., and Hunter V.J. The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J. Am. Coll. Nutr. 22 2 (2003) 118-123
18. Drisko J.A., Chapman J., and Hunter V.J. The use of antioxidant therapies during chemotherapy. Gynecol. Oncol. 88 3 (2003) 434-439
19. Serra J., and Soille P. Mathematical morphology and its applications to image processing (1994), Kluwer Academic Publisher, Dordrecht
20. Hahn M., Vogel M., Pompesius-Kempa M., and Delling G. Trabecular bone pattern factor-a new parameter for simple quantification of bone microarchitecture. Bone 13 4 (1992) 327-330
21. Chappard D. Technical aspects: How do we best prepare bone samples for proper histological analysis?. In: Heymann D. (Ed). Bone cancer: progression and therapeutic approaches (2009), Academic Press, London, UK 203-210
22. Devasagayam T.P., and Tarachand U. Decreased lipid peroxidation in the rat kidney during gestation. Biochem. Biophys. Res. Commun. 145 1 (1987) 134-138
23. Slater T.F., and Sawyer B.C. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used. Biochem. J. 123 5 (1971) 805-814
24. Fagan J.M., Sleczka B.G., and Sohar I. Quantitation of oxidative damage to tissue proteins. Int. J. Biochem. Cell Biol. 31 7 (1999) 751-757
25. Beers Jr. R.F., and Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195 1 (1952) 133-140
26. Beutler E., and Matsumoto F. Ethnic variation in red cell glutathione peroxidase activity. Blood 46 1 (1975) 103-110
27. McCord J.M., and Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J. Biol. Chem. 244 22 (1969) 6056-6063
28. Gunawardena K., Murray D.K., and Meikle A.W. Vitamin E and other antioxidants inhibit human prostate cancer cells through apoptosis. Prostate 44 4 (2000) 287-295
29. Royall J.A., and Ischiropoulos H. Evaluation of 2′,7′-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Arch. Biochem. Biophys. 302 2 (1993) 348-355
30. Wang H., and Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 27 5-6 (1999) 612-616
31. Guise T.A., and Mundy G.R. Cancer and bone. Endocr. Rev. 19 (1998) 18-54
32. Stepensky D., Golomb G., and Hoffman A. Pharmacokinetic and pharmacodynamic evaluation of intermittent versus continuous alendronate administration in rats. J. Pharm. Sci. 91 2 (2002) 508-516
33. Rizzoli R., and Fleisch H. The Walker 256/B carcinosarcoma in thyroparathyroidectomized rats: a model to evaluate inhibitors of bone resorption. Calcif. Tissue Int. 41 4 (1987) 202-207
34. 2MBP. Cancer 72 1 (1993) 91-98
35. Takagane A., Terashima M., Abe K., Araya M., Nishizuka S., and Saito K. Induction of cytokines in ascitic fluid by intraperitoneal OK-432 administration in patients with gastric cancer. J. Jpn. Soc. Cancer Ther. 31 11 (1996) 1067-1074
36. Gonenc A., Ozkan Y., Torun M., and Simsek B. Plasma malondialdehyde (MDA) levels in breast and lung cancer patients. J. Clin. Pharm. Ther. 26 2 (2001) 141-144
37. Lean J.M., Davies J.T., Fuller K., Jagger C.J., Kirstein B., Partington G.A., Urry Z.L., and Chambers T.J. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J. Clin. Invest. 112 6 (2003) 915-923
38. Jagger C.J., Lean J.M., Davies J.T., and Chambers T.J. Tumor necrosis factor-alpha mediates osteopenia caused by depletion of antioxidants. Endocrinology 146 1 (2005) 113-118
39. Kaya H., Delibas N., Serteser M., Ulukaya E., and Ozkaya O. The effect of melatonin on lipid peroxidation during radiotherapy in female rats. Strahlenther Onkol 175 6 (1999) 285-288
40. Moreau M.F., Gallois Y., Baslé M.F., and Chappard D. Gamma irradiation of human bone allografts alters medullary lipids and releases toxic compounds for osteoblast-like cells. Biomaterials 21 4 (2000) 369-376
41. Gamal el-din A.M., Mostafa A.M., Al-Shabanah O.A., Al-Bekairi A.M., and Nagi M.N. Protective effect of arabic gum against acetaminophen-induced hepatotoxicity in mice. Pharmacol. Res. 48 6 (2003) 631-635
42. Sener G., Sehirli A.O., and Ayanoglu-Dulger G. Protective effects of melatonin, vitamin E and N-acetylcysteine against acetaminophen toxicity in mice: a comparative study. J. Pineal Res. 35 1 (2003) 61-68
43. Sener G., Sehirli O., Cetinel S., Yegen B.G., Gedik N., and Ayanoglu-Dulger G. Protective effects of MESNA (2-mercaptoethane sulphonate) against acetaminophen-induced hepatorenal oxidative damage in mice. J. Appl. Toxicol. 25 1 (2005) 20-29
44. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and biology of ageing. Nature 408 (2000) 147-239
45. Liu X., Zhao J., and Zheng R. DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients. Mutat. Res. 539 1-2 (2003) 1-8
46. Garrett I.R., Boyce B.F., Oreffo R.O., Bonewald L., Poser J., and Mundy G.R. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 85 3 (1990) 632-639
47. Fraser J.H., Helfrich M.H., Wallace H.M., and Ralston S.H. Hydrogen peroxide, but not superoxide, stimulates bone resorption in mouse calvariae. Bone 19 3 (1996) 223-226
48. Mody N., Parhami F., Sarafian T.A., and Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic. Biol. Med. 31 4 (2001) 509-519
49. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., Li X.M., and Luo S.Q. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem. Biophys. Res. Commun. 314 1 (2004) 197-207
50. Iotsova V., Caamano J., Loy J., Yang Y., Lewin A., and Bravo R. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3 11 (1997) 1285-1289
51. Basu S., Michaelsson K., Olofsson H., Johansson S., and Melhus H. Association between oxidative stress and bone mineral density. Biochem. Biophys. Res. Commun. 288 1 (2001) 275-279
52. Steinbeck M.J., Appel Jr. W.H., Verhoeven A.J., and Karnovsky M.J. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J. Cell Biol. 126 3 (1994) 765-772
53. Guise T.A. Molecular mechanisms of osteolytic bone metastases. Cancer 88 12S (2000) 2892-2898
54. Yu W., Simmons-Menchaca M., Gapor A., Sanders B.G., and Kline K. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer 33 1 (1999) 26-32
55. Lawson K.A., Anderson K., Snyder R.M., Simmons-Menchaca M., Atkinson J., Sun L.Z., Bandyopadhyay A., Knight V., Gilbert B.E., Sanders B.G., and Kline K. Novel vitamin E analogue and 9-nitro-camptothecin administered as liposome aerosols decrease syngeneic mouse mammary tumor burden and inhibit metastasis. Cancer Chemother. Pharmacol. 54 5 (2004) 421-431
56. Morton D.J., Barrett-Connor E.L., Schneider D.L., and Vitamin. C supplement use and bone mineral density in postmenopausal women. J. Bone Miner. Res. 16 1 (2001) 135-140
57. Maggio D., Barabani M., Pierandrei M., Polidori M.C., Catani M., Mecocci P., Senin U., Pacifici R., and Cherubini A. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J. Clin. Endocrinol. Metab. 88 4 (2003) 1523-1527
58. Yilmaz S., and Yilmaz E. Effects of melatonin and vitamin E on oxidative-antioxidative status in rats exposed to irradiation. Toxicology 222 1-2 (2006) 1-7
59. Niki E., and Noguchi N. Dynamics of antioxidant action of vitamin E. Acc. Chem. Res. 37 1 (2004) 45-51
60. Brigelius-Flohe R., and Traber M.G. Vitamin E: function and metabolism. Faseb J. 13 10 (1999) 1145-1155
61. Choi K.S., Bae M.K., Jeong J.W., Moon H.E., and Kim K.W. Hypoxia-induced angiogenesis during carcinogenesis. J. Biochem. Mol. Biol. 36 1 (2003) 120-127
62. Ahmad N.S., Khalid B.A., Luke D.A., and Ima Nirwana S. Tocotrienol offers better protection than tocopherol from free radical-induced damage of rat bone. Clin. Exp. Pharmacol. Physiol. 32 9 (2005) 761-770